Generate Biomedicines, Inc. GENB
Set alert
13.40 USD -1.06 -7.33%
As of Nov 2, 1:42 PM ET
13.34 Day range 14.64
11.00 52-week range 22.67
- YTD
- +5.93%
- 1 year
- +5.93%
- Open
- 14.28
- Prev close
- 14.46
- Mkt cap
- 1.72B
- Vol
- 438.08K
- Avg vol
- 1.18M
- EPS
- -2.44
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.34
- High
- 14.64
- Forward P/E
- -6.39
- Beta
- 0.00
- Short ratio
- 7.37
- Inst. own
- 79.13%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 15.03
- 200-d avg
- 14.07
- 1y target
- 27.00
Financial health
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 2
Valuation
P/E -2.5×
FY 2024 5y median -5.0× FY 2025
P/S 19.9×
FY 2024 5y median 49.3× FY 2025
P/B -1.0×
FY 2024 5y median -2.4× FY 2025
P/FCF -3.1×
FY 2024 5y median -8.2× FY 2025
EV/EBITDA -2.8×
FY 2024 5y median -6.0× FY 2025
EV/Sales 18.2×
FY 2024 5y median 46.1× FY 2025
FCF Yield -32.2%
FY 2024 5y median -19.9% FY 2025
Profitability
Gross Margin 100.0%
FY 2024 5y median 100.0% FY 2025
Operating Margin -737.0%
FY 2024 5y median -849.8% FY 2025
Net Margin -637.0%
FY 2024 5y median -743.2% FY 2025
ROE 33.0%
FY 2024 5y median 36.5% FY 2025
ROIC -89.4%
FY 2024 5y median -66.7% FY 2025
ROA -61.5%
FY 2024 5y median -47.5% FY 2025
Growth (YoY)
Revenue 55.9%
FY 2024 FY 2025
Operating Income -19.4%
FY 2024 FY 2025
EPS (diluted) -196.4%
FY 2024 FY 2025
Free Cash Flow -68.4%
FY 2024 FY 2025
Financial Health
Current Ratio 2.9×
FY 2024 5y median 3.8× FY 2025
Quick Ratio 2.9×
FY 2024 5y median 3.8× FY 2025
Debt / Equity -0.1×
FY 2024 5y median -0.1× FY 2025
Net Debt / EBITDA 0.3×
FY 2024 5y median 0.4× FY 2025
Interest Coverage -207×
FY 2024 5y median -150× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31